Investing Profile

Jill carroll

Photo of Jill carroll, Principal at SR One
Your Intro Paths to Jill carroll

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks Jill is a member of
Duke University Network
88 CONNECTIONS

Find Jill carroll on

cb
Current Investing Position
SR One Principal
Investments On Record
7

Jill carroll's Investments On Record (5)

CompanyStageDateRound SizeTotal Raised
Avalyn Pharma
Series CSep 2023$180M
$210M
Co-investors: Robert Mittendorff (B Capital Group), Heather Preston
Odyssey Therapeutics
Series BOct 2022$170M
Series ADec 2021$220M
$490M
Co-investors: Elena Viboch (General Catalyst), Carl Gordon (OrbiMed), Lorence Kim (Third Rock Ventures)
HotSpot Therapeutics
Series CNov 2021$100M
Series BMay 2020$65M
$210M
Co-investors: Fouad Azzam (EQT Life Sciences), Bruce Booth (Atlas Venture), Graziano Seghezzi (Soffinova Partners), Ash Khanna (Pivotal bioVenture Partners)
Arch Oncology
Series AAug 2016$86M
$86M
Co-investors: Peter Moldt (Novo Ventures), John McKearn (RiverVest), Carole Nuechterlein (Roche Venture Fund)
AGTC
Series BNov 2012$38M
$38M
Co-investors: Bill Harrington (Osage University Partners), Ed Hurwitz (MPM Capital)

Jill carroll's Experience

Principal S.R. One Ltd2011 - Present
VP, Corporate Development Limerick Biopharma2010 - 2011
Sr Director, Strategic Planning & Corporate Development Dynavax Technologies2004 - 2010
Director, Market Analysis Clearview Projects2001 - 2004
Consultant Mercer Management Consulting1999 - 2001

Jill carroll's Education

Johns Hopkins University MS Biochemistry
Duke University BS Chemistry